Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir

Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of effectiveness of repurposed drugs and economic damage. COVID-19 pandemic has created an urgent need for effective molecules...

Descripción completa

Detalles Bibliográficos
Autores principales: Negru, Paul Andrei, Radu, Andrei-Flavius, Vesa, Cosmin Mihai, Behl, Tapan, Abdel-Daim, Mohamed M., Nechifor, Aurelia Cristina, Endres, Laura, Stoicescu, Manuela, Pasca, Bianca, Tit, Delia Mirela, Bungau, Simona Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813547/
https://www.ncbi.nlm.nih.gov/pubmed/35131656
http://dx.doi.org/10.1016/j.biopha.2022.112700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813547/
https://www.ncbi.nlm.nih.gov/pubmed/35131656
http://dx.doi.org/10.1016/j.biopha.2022.112700

Ejemplares similares